Title

The Kawasaki Disease Comparative Effectiveness (KIDCARE) trial: A phase III, randomized trial of second intravenous immunoglobulin versus infliximab for resistant Kawasaki disease.

Document Type

Journal Article

Publication Date

3-3-2019

Journal

Contemporary Clinical Trials

DOI

10.1016/j.cct.2019.02.008

Comments

Epub ahead of print

Peer Reviewed

1

This document is currently not available here.

Share

COinS